143 related articles for article (PubMed ID: 9149748)
1. DDAVP therapy controls bleeding in Ehlers-Danlos syndrome.
Stine KC; Becton DL
J Pediatr Hematol Oncol; 1997; 19(2):156-8. PubMed ID: 9149748
[TBL] [Abstract][Full Text] [Related]
2. Desmopressin responsiveness in children with Ehlers-Danlos syndrome associated bleeding symptoms.
Mast KJ; Nunes ME; Ruymann FB; Kerlin BA
Br J Haematol; 2009 Jan; 144(2):230-3. PubMed ID: 19036109
[TBL] [Abstract][Full Text] [Related]
3. Ehlers-Danlos syndrome, type VIII presenting with periodontitis and prolonged bleeding time.
Cunniff C; Williamson-Kruse L
Clin Dysmorphol; 1995 Apr; 4(2):145-9. PubMed ID: 7606321
[TBL] [Abstract][Full Text] [Related]
4. Low-dose intranasal desmopressin (DDAVP) for uremic bleeding.
Ozen S; Saatci U; Bakkaloglu A; Ozdemir S; Ozdemir O; Besbas N
Nephron; 1997; 75(1):119-20. PubMed ID: 9031290
[No Abstract] [Full Text] [Related]
5. [Desmopressin in the treatment of hemorrhagic diathesis].
Haar D; Hasselbalch HC
Ugeskr Laeger; 1995 Nov; 157(48):6713-5. PubMed ID: 8540136
[TBL] [Abstract][Full Text] [Related]
6. The clinical significance of different routes of desmopressin (DDAVP) administration in various bleeding disorders.
Mörsdorf S; Köhler M; Leipnitz G; Wenzel E
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):503-7. PubMed ID: 2465962
[TBL] [Abstract][Full Text] [Related]
7. Hemostatic and hemodynamic effects of vasopressin analogue DDAVP in patients with cirrhosis.
López P; Otaso JC; Alvarez D; Rojter S; Podestá A; Albornoz L; Terg R; Romero G; Mastai R
Acta Gastroenterol Latinoam; 1997; 27(2):59-62. PubMed ID: 9339235
[TBL] [Abstract][Full Text] [Related]
8. Desmopressin: a nontransfusional hemostatic agent.
Mannucci PM
Annu Rev Med; 1990; 41():55-64. PubMed ID: 2184748
[TBL] [Abstract][Full Text] [Related]
9. Patients with prolonged bleeding time of undefined etiology, and their response to desmopressin.
Kim HC; Salva K; Fallot PL; Karp GI; Eisele J; Matts L; Heller I; Saidi P
Thromb Haemost; 1988 Apr; 59(2):221-4. PubMed ID: 3388295
[TBL] [Abstract][Full Text] [Related]
10. Utilization and Effectiveness of Desmopressin Acetate After Cardiac Surgery Supplemented With Point-of-Care Hemostatic Testing: A Propensity-Score-Matched Analysis.
Orlov D; McCluskey SA; Callum J; Rao V; Moreno J; Karkouti K
J Cardiothorac Vasc Anesth; 2017 Jun; 31(3):883-895. PubMed ID: 28169116
[TBL] [Abstract][Full Text] [Related]
11. Desmopressin (DDAVP) in bleeding disorders of childhood.
Sutor AH
Semin Thromb Hemost; 1998; 24(6):555-66. PubMed ID: 10066151
[TBL] [Abstract][Full Text] [Related]
12. The influence of desmopressin on blood loss during spinal fusion surgery in neuromuscular patients.
Letts M; Pang E; D'Astous J; Jarvis J; Lawton L; Luke B; Rhine E; Menard E
Spine (Phila Pa 1976); 1998 Feb; 23(4):475-8. PubMed ID: 9516704
[TBL] [Abstract][Full Text] [Related]
13. Does desmopressin improve hemostasis and reduce blood loss from aortic surgery? A randomized, double-blind study.
Clagett GP; Valentine RJ; Myers SI; Chervu A; Heller J
J Vasc Surg; 1995 Sep; 22(3):223-9; discussion 229-30. PubMed ID: 7674464
[TBL] [Abstract][Full Text] [Related]
14. The use of prophylactic desmopressin (DDAVP) in labor to prevent hemorrhage in a patient with Ehlers-Danlos syndrome.
Rochelson B; Caruso R; Davenport D; Kaelber A
N Y State J Med; 1991 Jun; 91(6):268-9. PubMed ID: 1861812
[No Abstract] [Full Text] [Related]
15. Desmopressin-induced improvement in bleeding times in chronic renal failure patients correlates with platelet serotonin uptake and ATP release.
Soslau G; Schwartz AB; Putatunda B; Conroy JD; Parker J; Abel RF; Brodsky I
Am J Med Sci; 1990 Dec; 300(6):372-9. PubMed ID: 2264575
[TBL] [Abstract][Full Text] [Related]
16. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
[TBL] [Abstract][Full Text] [Related]
17. [Hemostatic control in platelet dysfunction and abnormality by DDAVP].
Mito M; Higuchi W; Fuse I; Hattori A; Shibata A
Nihon Rinsho; 1992 Feb; 50(2):355-9. PubMed ID: 1613990
[TBL] [Abstract][Full Text] [Related]
18. The use of desmopressin in children with coagulation disorders.
Brown OE
Int J Pediatr Otorhinolaryngol; 1986 Sep; 11(3):301-5. PubMed ID: 3771110
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo effects of desmopressin on platelet function.
Balduini CL; Noris P; Belletti S; Spedini P; Gamba G
Haematologica; 1999 Oct; 84(10):891-6. PubMed ID: 10509036
[TBL] [Abstract][Full Text] [Related]
20. Desmopressin (DDAVP) for treatment of disorders of hemostasis.
Mannucci PM
Prog Hemost Thromb; 1986; 8():19-45. PubMed ID: 3104987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
